BPC
ALNY icon

Banque Pictet & Cie’s Alnylam Pharmaceuticals ALNY Stock Holding History

Banque Pictet & Cie’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,120
Closed -$445K – 391
2025
Q4 		$445K Sell
1,120
-265
-19% -$117K ﹤0.01% 310
2025
Q3 		$632K Sell
1,385
-6
-0.4% -$2.44K ﹤0.01% 292
2025
Q2 		$454K Sell
1,391
-92
-6% -$25.5K ﹤0.01% 296
2025
Q1 		$400K Buy
+1,483
New +$381K ﹤0.01% 326
2024
Q2 		– Sell
-33,005
Closed -$4.93M – 300
2024
Q1 		$4.93M Buy
33,005
+10,176
+45% +$1.7M 0.05% 149
2023
Q4 		$4.37M Sell
22,829
-2,595
-10% -$442K 0.04% 161
2023
Q3 		$4.5M Sell
25,424
-1,154
-4% -$220K 0.05% 152
2023
Q2 		$5.05M Buy
26,578
+21,471
+420% +$4.26M 0.04% 166
2023
Q1 		$1.02M Sell
5,107
-2,316
-31% -$487K 0.01% 381
2022
Q4 		$1.76M Sell
7,423
-4,910
-40% -$1.05M 0.02% 308
2022
Q3 		$2.47M Buy
12,333
+4,991
+68% +$952K 0.03% 253
2022
Q2 		$1.07M Sell
7,342
-4,432
-38% -$629K 0.01% 419
2022
Q1 		$1.92M Sell
11,774
-4,707
-29% -$717K 0.01% 341
2021
Q4 		$2.79M Buy
+16,481
New +$3.06M 0.02% 283

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Banque Pictet & Cie's ALNY Position: Q1 2026 in Review

Banque Pictet & Cie sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 1,120 shares — an estimated $445K sold.

Banque Pictet & Cie first reported a position in ALNY in Q4 2021 and held it in 14 quarters. The position peaked at $5.05M in Q2 2023. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Banque Pictet & Cie reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Banque Pictet & Cie sold 1,120 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $445K.
  • Banque Pictet & Cie first reported a position in Alnylam Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Banque Pictet & Cie's Alnylam Pharmaceuticals position peaked at $5.05M in Q2 2023.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.